Skip NavigationSkip to Content

A Small Molecule Stabilizer of the MYC G4-Quadruplex Induces Endoplasmic Reticulum Stress, Senescence and Pyroptosis in Multiple Myeloma

  1. Author:
    Gaikwad, Snehal M [ORCID]
    Phyo, Zaw
    Arteaga, Anaisa Quintanilla
    Gorjifard, Sayeh
    Calabrese,Dave
    Connors, Daniel
    Huang, Jing
    Michalowski, Aleksandra M
    Zhang, Shuling
    Liu, Zheng-Gang
    Schneekloth,Jay
    Mock, Beverly A
  2. Author Address

    Laboratory of Cancer Biology and Genetics, National Cancer Institute, NIH, Bethesda, MD 20892, USA., Chemical Biology Laboratory, National Cancer Institute, NIH, Frederick, MD 21702, USA., NCATS, NIH, Rockville, MD 20850, USA., Laboratory of Immune Cell Biology, National Cancer Institute, NIH, Bethesda, MD 20892, USA.,
    1. Year: 2020
    2. Date: Oct 13
    3. Epub Date: 2020 10 13
  1. Journal: Cancers
    1. 12
    2. 10
    3. Pages: pii: E2952
  2. Type of Article: Article
  3. Article Number: 2952
  4. ISSN: 2072-6694
  1. Abstract:

    New approaches to target MYC include the stabilization of a guanine-rich, G-quadruplex (G4) tertiary DNA structure in the NHE III region of its promoter. Recent screening of a small molecule microarray platform identified a benzofuran, D089, that can stabilize the MYC G4 and inhibit its transcription. D089 induced both dose- and time-dependent multiple myeloma cell death mediated by endoplasmic reticulum induced stress. Unexpectedly, we uncovered two mechanisms of cell death: cellular senescence, as evidenced by increased levels of p16, p21 and ?-H2AX proteins and a caspase 3-independent mechanism consistent with pyroptosis. Cells treated with D089 exhibited high levels of the cleaved form of initiator caspase 8; but failed to show cleavage of executioner caspase 3, a classical apoptotic marker. Cotreatment with the a pan-caspase inhibitor Q-VD-OPh did not affect the cytotoxic effect of D089. In contrast, cleaved caspase 1, an inflammatory caspase downstream of caspases 8/9, was increased by D089 treatment. Cells treated with D089 in addition to either a caspase 1 inhibitor or siRNA-caspase 1 showed increased IC50 values, indicating a contribution of cleaved caspase 1 to cell death. Downstream effects of caspase 1 activation after drug treatment included increases in IL1B, gasdermin D cleavage, and HMGB1 translocation from the nucleus to the cytoplasm. Drug treated cells underwent a 39;ballooning 39; morphology characteristic of pyroptosis, rather than 39;blebbing 39; typically associated with apoptosis. ASC specks colocalized with NLRP3 in proximity ligation assays after drug treatment, indicating inflammasome activation and further confirming pyroptosis as a contributor to cell death. Thus, the small molecule MYC G4 stabilizer, D089, provides a new tool compound for studying pyroptosis. These studies suggest that inducing both tumor senescence and pyroptosis may have therapeutic potential for cancer treatment.

    See More

External Sources

  1. DOI: 10.3390/cancers12102952
  2. PMID: 33066043
  3. WOS: 000584577200001
  4. PII : cancers12102952

Library Notes

  1. Fiscal Year: FY2020-2021
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel